Cargando…

Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases

The complement system consists of effector proteins, regulators, and receptors that participate in host defense against pathogens. Activation of the complement system, via the classical pathway (CP), has long been recognized in immune complex-mediated tissue injury, most notably systemic lupus eryth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lintner, Katherine E., Wu, Yee Ling, Yang, Yan, Spencer, Charles H., Hauptmann, Georges, Hebert, Lee A., Atkinson, John P., Yu, C. Yung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753731/ https://www.ncbi.nlm.nih.gov/pubmed/26913032 http://dx.doi.org/10.3389/fimmu.2016.00036

Ejemplares similares

Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway
por: Macedo, Ana Catarina Lunz, et al.
Publicado: (2016)

A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway
por: Mutti, Michele, et al.
Publicado: (2018)

Distinct Roles of Classical and Lectin Pathways of Complement in Preeclamptic Placentae
por: Belmonte, Beatrice, et al.
Publicado: (2022)

Carbamylation of immunoglobulin abrogates activation of the classical complement pathway
por: Koro, Catalin, et al.
Publicado: (2014)

Editorial: State-of-the-Art Research on C1q and the Classical Complement Pathway
por: Kishore, Uday, et al.
Publicado: (2016)

Complementary Roles of the Classical and Lectin Complement Pathways in the Defense against Aspergillus fumigatus
por: Rosbjerg, Anne, et al.
Publicado: (2016)

Complement Therapeutics in Autoimmune Disease
por: Thurman, Joshua M., et al.
Publicado: (2019)

Editorial: The complement system in autoimmunity
por: Wu, Eveline Y., et al.
Publicado: (2022)

Complement Component C4 Regulates the Development of Experimental Autoimmune Uveitis through a T Cell-Intrinsic Mechanism
por: Zhang, Lingjun, et al.
Publicado: (2017)

The Classical Complement Pathway Is Required to Control Borrelia burgdorferi Levels During Experimental Infection
por: Zhi, Hui, et al.
Publicado: (2018)

Molluskan Hemocyanins Activate the Classical Pathway of the Human Complement System through Natural Antibodies
por: Pizarro-Bauerle, Javier, et al.
Publicado: (2017)

Human Complement C4B Allotypes and Deficiencies in Selected Cases With Autoimmune Diseases
por: Zhou, Danlei, et al.
Publicado: (2021)

Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases
por: Dobó, József, et al.
Publicado: (2018)

Complement C4, Infections, and Autoimmune Diseases
por: Wang, Hongbin, et al.
Publicado: (2021)

Functional and Structural Characterization of a Potent C1q Inhibitor Targeting the Classical Pathway of the Complement System
por: Laursen, Nick S., et al.
Publicado: (2020)

The axis of complement C1 and nucleolus in antinuclear autoimmunity
por: Wu, Shan, et al.
Publicado: (2023)

Peptide Inhibitor of Complement C1, a Novel Suppressor of Classical Pathway Activation: Mechanistic Studies and Clinical Potential
por: Sharp, Julia A., et al.
Publicado: (2014)

Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review
por: Edwards, Gareth, et al.
Publicado: (2019)

Classical and Non-classical Presentations of Complement Factor I Deficiency: Two Contrasting Cases Diagnosed via Genetic and Genomic Methods
por: Shields, Adrian M., et al.
Publicado: (2019)

Evasion of Classical Complement Pathway Activation on Plasmodium falciparum-Infected Erythrocytes Opsonized by PfEMP1-Specific IgG
por: Larsen, Mads Delbo, et al.
Publicado: (2019)

Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation
por: Tang, Guo-Qing, et al.
Publicado: (2023)

Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation
por: Tang, Guo-Qing, et al.
Publicado: (2023)

Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways
por: Lilienthal, Gina-Maria, et al.
Publicado: (2018)

Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs
por: Hurler, Lisa, et al.
Publicado: (2022)

Adipsin of the Alternative Complement Pathway Is a Potential Predictor for Preeclampsia in Early Pregnancy
por: Liu, Min, et al.
Publicado: (2021)

C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway
por: Wu, Wen-Jun, et al.
Publicado: (2020)

Association of complement components with the risk and severity of NAFLD: A systematic review and meta-analysis
por: Zhao, Jianbo, et al.
Publicado: (2022)

Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice
por: Mihai, Sidonia, et al.
Publicado: (2018)

The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2020)

A Targeted Complement Inhibitor CRIg/FH Protects Against Experimental Autoimmune Myasthenia Gravis in Rats via Immune Modulation
por: Song, Jie, et al.
Publicado: (2022)

Key Components of the Complement Lectin Pathway Are Not Only Required for the Development of Inflammatory Arthritis but Also Regulate the Transcription of Factor D
por: Holers, V. Michael, et al.
Publicado: (2020)

Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway
por: Barratt, Jonathan, et al.
Publicado: (2021)

The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence
por: Ramírez-Toloza, Galia, et al.
Publicado: (2020)

The Dendritic Cell Response to Classic, Emerging, and Homeostatic Danger Signals. Implications for Autoimmunity
por: Gallo, Paul M., et al.
Publicado: (2013)

Antibody-independent complement activation by myelin via the classical complement pathway
Publicado: (1982)

Complement lectin pathway components MBL and MASP-1 promote haemostasis upon vessel injury in a microvascular bleeding model
por: Golomingi, Murielle, et al.
Publicado: (2022)

Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis
por: Lubbers, Rosalie, et al.
Publicado: (2018)

Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients
por: Lage, Silvia Lucena, et al.
Publicado: (2022)

Complement Regulator FHR-3 Is Elevated either Locally or Systemically in a Selection of Autoimmune Diseases
por: Schäfer, Nicole, et al.
Publicado: (2016)

Molecular Characterization of Complement Component 3 (C3) in the Pearl Oyster Pinctada fucata Improves Our Understanding of the Primitive Complement System in Bivalve
por: Wang, Zhongliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_irl4ps4tjhkg8c5oufaca87bgp